Suzanne A Lebold

Title: Suzanne A. Lebold: Innovator in Neurotransmitter Control

Introduction

Suzanne A. Lebold is a prominent inventor based in Chicago, IL (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that influence neurotransmitter release. With a total of 5 patents to her name, her work has the potential to impact therapeutic approaches for various medical conditions.

Latest Patents

Among her latest patents, one notable invention is focused on heterocyclic ether compounds that are useful in controlling neurotransmitter release. This patent describes novel compounds that can selectively activate or inhibit neurotransmitter release, along with their pharmaceutical compositions. Another significant patent involves bicyclic substituted hexahydrobenz isoindole alpha-1 adrenergic antagonists, which are useful in treating benign prostatic hyperplasia (BPH). These compounds and their compositions provide a method for antagonizing alpha-1 receptors, showcasing her innovative approach to addressing medical challenges.

Career Highlights

Suzanne A. Lebold is associated with Abbott Laboratories Corporation, a leading company in the pharmaceutical industry. Her work at Abbott has allowed her to focus on groundbreaking research and development in the field of drug formulation and neurotransmitter modulation.

Collaborations

Throughout her career, Suzanne has collaborated with esteemed colleagues such as Edmund L. Lee and Michael D. Meyer. These partnerships have contributed to the advancement of her research and the successful development of her patented inventions.

Conclusion

Suzanne A. Lebold's contributions to the field of pharmaceuticals through her innovative patents highlight her role as a key inventor in neurotransmitter control. Her work continues to pave the way for new therapeutic options in medicine.